Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Evaluation of a Mobile Application to Facilitate the Interpretation of Spirometry by Family Physicians and Residents

8. Oktober 2020 aktualisiert von: Louis-Philippe Boulet, Laval University

Evaluation of a Mobile Application to Facilitate the Interpretation of the Spirometry Test by Family Physicians and Family Medicine Residents: Impact on Prescription and Interpretation of This Test

Problematic: Spirometry is used to objectify the obstructive syndrome defining chronic obstructive pulmonary disease (COPD). However, this test remains underused in the primary care. The tools available for its interpretation are little used and the existence of several decision algorithms can create confusion during the diagnosis.

Principal objective: To evaluate the impact of a mobile application (SPIRO©) on medical practice (interpretation and prescription of spirometry) of family physicians and family medicine residents working in family medicine units (FMU) in Quebec affiliated with Laval University.

Secondary objective : To evaluate the usability of SPIRO© among family physicians and residents in family medicine working in FMU in Quebec affiliated with Laval University.

Methods: This is a pre-post clinical trial with control group. Participants (family MD and family medicine residents) will be recruited from the various FMU affiliated with Laval University. Participants working in the FMU in the experimental group will be able to use the SPIRO® mobile application to facilitate interpretation of the spirometry test results while participants in the control group will not have access to it during the study. The basic characteristics of the participants and various behavioral parameters based on the theory of planned behavior concerning the interpretation and prescription of spirometry test will be measured. Data from the control group will be collected before those in the experimental group at the time the application is not yet available, which will minimize contamination between groups. The data will be collected with questionnaires delivered in person to the participants before the intervention (T0 time) and then four months later (T1 time) during their team or research meeting. Participants will be recruited in eight of the 12 Quebec FMU affiliated with Laval University, who will be randomly assigned to two equal groups: control and experimental. The intervention will consist in sending the SPIRO© mobile application to participants in the experimental group who will use it for a period of four months.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

Hypothesis : The investigators hypothesize that the use of the SPIRO© application will increase the skills and confidence of family physicians and family medicine residents in prescribing and interpreting spirometry compared to the control group.

The project will be conducted in the following six major steps: 1) Collection of socio-demographic and behavioral characteristics of participants using sections A, B, C and D of the NAPI questionnaire in the control group; 2) Intervention in the control group (they will continue their daily medical practice without being subject to any intervention by our research team), for a period of 4 months; 3) Measurement of behavioral changes in the control group using Sections B, C, D and E of the NAPI questionnaire 4 months after the start of the study; 4) Collection of socio-demographic and behavioral data from participants in the experimental group using sections A, B, C and D of the NAPI questionnaire; 5) E-mail distribution of the application and use of the application by participants in the experimental group for a period of four months, 6) Measurement of behavioral changes in the experimental group after the use of the application, Using sections B, C, D and E of the NAPI questionnaire as well as a questionnaire on the application SPIRO© (SPIRO questionnaire) which will evaluate the usability of this one.

The study has been approved by the research ethic board of the Health and Social Services Center of the old capital - attached to the Integrated Center for Health and Social Services of the National Capital.

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

104

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

  • Kanada
    • Quebec
      • Baie-Comeau, Quebec, Kanada, G4Z 3B8
        • UMF de Manicouagan
      • Gaspé, Quebec, Kanada, G4X 2W2
        • UMF de Gaspé
      • Lac-Etchemin, Quebec, Kanada, G0R 1S0
        • UMF des Etchemins
      • Lévis, Quebec, Kanada, G6W 0J4
        • UMF de Lévis
      • Quebec City, Quebec, Kanada, G1J 2G1
        • Unité de médecine familiale - GMF Maizerets
      • Quebec City, Quebec, Kanada, G1L 3L5
        • UMF Saint-François d'Assise
      • Quebec City, Quebec, Kanada, G1V 0B7
        • Unité de médecine familiale Laval
      • Trois-Pistoles, Quebec, Kanada, G0L 4K0
        • UMF de Trois-Pistoles

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

Primary care physicians and residents in family medicine of 18 years old or more working in one of the 12 family medicine units in Quebec affiliated with Laval University.

Beschreibung

Inclusion Criteria:

  • Participants need to be primary care physicians or residents in family medicine of 18 years old or more working in one of the 12 family medicine units in Quebec affiliated with Laval University.

Exclusion Criteria:

  • Health professionals not practicing family medicine and residents of other specialties will not be eligible. Individuals who participated in the development of the " subjective Norms, Attitudes, Perceived behavioral control, Intentions (NAPI) " questionnaires (apparent validation) will be excluded.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: Kohorte
  • Zeitperspektiven: Interessent

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Control Group
Primary care physicians and residents in family medicine of family medicine units affiliated with Laval University.
Experimental Group
Primary care physicians and residents in family medicine of family medicine units affiliated with Laval University that will use the mobile application SPIRO(c) for a period of four months.
Gerät: SPIRO
Participants in the Experimental Group will be asked to use SPIRO mobile application during a period of 4 months.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Beliefs about capabilities - interpretation
Zeitfenster: six weeks
The beliefs about the capabilities of primary care physicians and residents in family medicine regarding interpretation of spirometry.
six weeks

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Beliefs about consequences - prescription
Zeitfenster: six weeks
The beliefs about the consequences of primary care physicians and residents in family medicine regarding prescription of spirometry.
six weeks
Beliefs about consequences - interpretation
Zeitfenster: six weeks
The beliefs about the consequences of primary care physicians and residents in family medicine regarding interpretation of spirometry.
six weeks
Beliefs about consequences - use of a mobile application
Zeitfenster: six weeks
The beliefs about the consequences of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
six weeks
Moral norms - prescription
Zeitfenster: six weeks
The beliefs about the moral norms of primary care physicians and residents in family medicine regarding prescription of spirometry.
six weeks
Moral norms - interpretation
Zeitfenster: six weeks
The beliefs about the moral norms of primary care physicians and residents in family medicine regarding interpretation of spirometry.
six weeks
Moral norms - use of a mobile application
Zeitfenster: six weeks
The beliefs about the moral norms of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
six weeks
Intentions - prescription
Zeitfenster: six weeks
The beliefs about the intentions of primary care physicians and residents in family medicine regarding prescription of spirometry.
six weeks
Intentions - interpretation
Zeitfenster: six weeks
The beliefs about the intentions of primary care physicians and residents in family medicine regarding interpretation of spirometry.
six weeks
Intentions - use of a mobile application
Zeitfenster: six weeks
The beliefs about the intentions of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
six weeks
Social influence - prescription
Zeitfenster: six weeks
The beliefs about the social influence of primary care physicians and residents in family medicine regarding prescription of spirometry.
six weeks
Social influence - interpretation
Zeitfenster: six weeks
The beliefs about the social influence of primary care physicians and residents in family medicine regarding interpretation of spirometry.
six weeks
Social influence - use of a mobile application
Zeitfenster: six weeks
The beliefs about the social influence of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
six weeks
Belief about capabilities - prescription
Zeitfenster: six weeks
The beliefs about the belief about capabilities of primary care physicians and residents in family medicine regarding prescription of spirometry.
six weeks
Belief about capabilities - use of a mobile application
Zeitfenster: six weeks
The beliefs about the belief about capabilities of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
six weeks

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Laval University

Ermittler

  • Hauptermittler: Louis-Philippe Boulet, MD, Heart and Lung Institute

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Oktober 2016

Primärer Abschluss (Tatsächlich)

7. Juli 2017

Studienabschluss (Tatsächlich)

20. Dezember 2017

Studienanmeldedaten

Zuerst eingereicht

26. Juni 2017

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

29. Juni 2017

Zuerst gepostet (Tatsächlich)

2. Juli 2017

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

12. Oktober 2020

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

8. Oktober 2020

Zuletzt verifiziert

1. Oktober 2020

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Schlüsselwörter

Andere Studien-ID-Nummern

  • SPIRO-MD Residents

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

Unentschieden

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur COPD

Klinische Studien zur SPIRO

Suchen Sie nach ähnlichen Studien

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

CROs by country

CROs in Norway

Bedingungen

Seltene Krankheiten

Drogeninterventionen

Nahrungsergänzungsmittel

Sponsor / Mitarbeiter

Standorte

Abonnieren